Young cancer patients with private insurance survive longer due to better access to care and treatment. Coverage instability worsens outcomes, but policy changes could help.
Cancer is no longer just a disease of older adults. Diagnoses among teenagers and young adults have been climbing steadily over the past decade, raising new concerns about how this age group is diagnosed and treated.
Research also shows that the type of health insurance adolescents and young adults have plays a major role in how early their cancer is detected and how long they survive.
As researchers who study cancer disparities in young adults, we examine the social and systemic factors that shape who survives a cancer diagnosis. In our recent review of the scientific literature—an analysis that included nearly 470,000 Americans between the ages of 15 and 39 who had been diagnosed with cancer—we found that insurance status is one of the clearest and most consequential factors.
Young patients with private insurance consistently lived longer than those with Medicaid or no insurance. The difference varied by cancer type. For lymphoma, privately insured patients had about an 8% lower risk of death. For melanoma and several other cancers, their risk of death was two to two and a half times lower.
Insurance Instability in Ages 15–39
People between the ages of 15 and 39 have especially unstable access to health coverage in the U.S.
Young people in this age group are often finishing school or starting new jobs, including positions that don’t offer benefits. They’re also aging off a parent’s insurance plan, which happens when you turn 26 under current U.S. law. This instability leaves many young people uninsured or underinsured.
